Seres Therapeutics Inc (MCRB)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
35,357,600
EV to revenue ratio (TTM)
43.3
EV to ebitda
3.276
Financial Performance
Revenue (TTM)
1,883,000
Gross profit (TTM)
-46,081,000
EBITDA
-74,778,000
Profitability
Operating margin (TTM)
-2,101.00%
Profit margin
0.00%
Return on assets (TTM)
-39.90%
Return on equity (TTM)
-66.60%
Per Share Metrics
Revenue per share (TTM)
0.2
EPS
-2.42
Diluted EPS (TTM)
-2.42
Book value
3.51
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
10.26
PEG ratio
-0.11
Price to sales ratio (TTM)
18.78
Price to book ratio (TTM)
1.172
Growth
Quarterly earnings growth (YoY)
-93.40%
Quarterly revenue growth (YoY)
-91.90%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.215